Shanghai, China

Zhijie Weng


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2008-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zhijie Weng: A Pioneer in Neuropharmaceutical Innovations

Introduction

Zhijie Weng is an innovative inventor based in Shanghai, China, known for his contributions to the field of neuropharmaceuticals. With a total of two patents to his name, Weng has focused his research on developing compounds that demonstrate significant potential in treating mental health conditions, particularly depression.

Latest Patents

Weng's latest patents include groundbreaking work on 1-butyl-2-hydroxyaralkyl piperazine derivatives. This invention reveals their potential use as antidepressants, showcasing a triple inhibition effect on the reuptake of serotonin (5-HT), norepinephrine (NA), and dopamine (DA). These derivatives can be administered in various forms, such as oral compositions or injections, to patients in need. Compared to existing dual-target antidepressants like venlafaxine, Weng's derivatives offer stronger efficacy, broader indications, faster onset, and lower levels of neurotoxicity and side effects. Furthermore, they exhibit higher bioavailability and longer half-lives, making them highly promising drug candidates.

Another significant patent by Weng focuses on aralkyl formyl-alkyl piperazine derivatives, highlighting their applications as cerebral nerve protective agents. The pharmaceutical compositions containing these derivatives have shown excellent neuroprotective activities combined with fewer side effects, contributing to advancements in neuropharmacology.

Career Highlights

Zhijie Weng has made significant strides in the pharmaceutical industry, having worked at renowned institutions such as the Shanghai Institute of Pharmaceutical Industry and Cspc Zhonggi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. His dedication to research and development in neuropharmaceuticals has led to innovative solutions for mental health challenges.

Collaborations

Throughout his career, Weng has collaborated with esteemed colleagues, including Jianqi Li and Liying Huang. These partnerships have fostered an environment of innovation, allowing for the exchange of ideas and insights that enhance the development of effective pharmaceuticals.

Conclusion

Zhijie Weng stands out as a prominent figure in the field of neuropharmaceuticals, with a focus on developing innovative treatments for depression and neuroprotection. His contributions through patents and collaborations are making a significant impact in the pharmaceutical community, offering hope for better mental health treatments in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…